Abnormal Tissue Growth: Hyperplasia, Dysplasia, and Neoplasia — Definitions and Examples

Pathology classifies abnormal tissue growth into a spectrum of increasing severity: hyperplasia → dysplasia → neoplasia. Understanding the distinctions is essential for diagnosis, risk stratification, and management.

1. Hyperplasia

Definition: Increase in the number of cells in a tissue/organ, resulting in enlargement. Cells remain normal in appearance and organization; process is reversible if stimulus removed.

Mechanisms: Hormonal stimulation, growth factors, compensatory response, chronic irritation.

Example	Stimulus	Clinical Note
Endometrial hyperplasia	Unopposed estrogen	Risk for endometrial carcinoma if atypical
Benign prostatic hyperplasia (BPH)	Androgens, aging	LUTS; not premalignant
Compensatory hepatic hyperplasia	Resection / injury	Regeneration; controlled
Thyroid hyperplasia (goiter)	Iodine deficiency / TSH	May be nodular
Skin (psoriasis, callus)	Friction, cytokines	Reversible with stimulus removal

2. Dysplasia

Definition: Disordered growth with cellular atypia (nuclear hyperchromasia, pleomorphism, mitotic figures) and architectural disturbance (loss of polarity, stratification). It is pre-neoplastic — not cancer, but increased malignant potential. Graded: mild / low-grade vs. moderate-severe / high-grade.

Example	Site	Etiology / Risk
Cervical intraepithelial neoplasia (CIN 1–3)	Cervix	HPV 16/18; CIN3 = carcinoma in situ
Barrett's esophagus with dysplasia	Distal esophagus	Chronic GERD → intestinal metaplasia → dysplasia → adenocarcinoma
Bronchial dysplasia	Bronchial epithelium	Smoking; precursor to squamous cell carcinoma
Colonic adenoma (tubular/villous) with dysplasia	Colon	Villous + high-grade = high cancer risk
Actinic keratosis	Skin	UV damage; field cancerization

3. Neoplasia

Definition: Autonomous, irreversible new growth of cells that exceeds and is uncoordinated with normal tissue. Clonal origin (genetic/epigenetic alterations). Classified as:

Type	Behavior	Examples
Benign neoplasm	Slow, expansile, encapsulated; no invasion/metastasis	Leiomyoma (fibroid), lipoma, adenoma, meningioma
Malignant neoplasm (Cancer)	Invasive, destructive, metastasizes	Carcinoma, sarcoma, lymphoma, leukemia, melanoma
Borderline / Uncertain	Low malignant potential	Ovarian borderline tumor, GIST (very low risk)

Progression Model

Normal → Hyperplasia → Dysplasia (low → high grade) → Carcinoma in situ → Invasive carcinoma → Metastasis

Not all steps occur in every tissue; some hyperplasias never progress; some cancers arise de novo.

Clinical Takeaway

• Hyperplasia: monitor / remove stimulus.
• Dysplasia: surveil, ablate, or excise based on grade/site.
• Neoplasia: stage, molecular profile, multidisciplinary treatment.

Precise terminology guides appropriate intervention and patient counseling.